Trials / Active Not Recruiting
Active Not RecruitingNCT05914883
The NORwegian Atrial Fibrillation Self-SCREENing
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50,000 (actual)
- Sponsor
- Oslo University Hospital · Academic / Other
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Accepted
Summary
Atrial fibrillation (AF) is common, increases the risk of mortality, stroke and heart failure, and portending significant burden to patients, societal health and health economy. One of three AF cases are undiagnosed. Several methods for detection of AF exist, but most of them have major limitations and are associated with resource-demanding diagnostic workup in the speciality health care services.
Detailed description
This randomized clinical trial will evaluate whether self-screening for AF with the ECG247 patch monitor will reduce AF-related morbidity.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Long-term continuous ECG monitoring | Long-term continuous ECG monitoring with ECG247 Smart Heart Sensor |
Timeline
- Start date
- 2023-09-01
- Primary completion
- 2029-12-01
- Completion
- 2029-12-31
- First posted
- 2023-06-22
- Last updated
- 2025-07-29
Locations
1 site across 1 country: Norway
Source: ClinicalTrials.gov record NCT05914883. Inclusion in this directory is not an endorsement.